The CADET Trial

Do you have depression?

Are you interested in a new potential treatment?

Kardinia Health is supporting a new treatment trial for depression run by Barwon Health and Deakin University.

The Aim

There is evidence to support the repurposing of commonly prescribed medications that may have anti-depressant properties. The Deakin University led trial aims to assess if this well-tolerated blood pressure medication, added to your usual treatment, may help reduce symptoms of depression in major depressive disorder and bipolar disorder, and improve quality of life.

The Reason

Depression may be linked to inflammation and stress in the brain. Some medications can help reduce this and protect brain cells. The medication in this trial may help improve symptoms of depression, and you could be part of finding out.

Key things to know

• No costs for participants to be involved in the trial.
• Participants can continue their usual treatments if there are no known interactions with the study medication.
• Once enrolled in the trial, participants will receive a reimbursement of $20 for each completed visit to cover travel expenses.
• Participation runs for 16 weeks
• Site study visits will be required every 2 to 4 weeks throughout the trial, or you can select the online visit option.
• Participants will be randomly assigned to receive either the active study medication or a placebo (which looks the same but has no active ingredient).
• Safety will be monitored throughout the trial by having blood tests and taking blood pressure readings at study visits.

Find out how you can be part of a trial aimed at reducing depression.

Ask your Kardinia Health GP or contact the CADET Trial team:

Email: cadet-trial@deakin.edu.au

Scan the QR code below: